US Broker Ratings

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Uncovering a 218% Upside Potential in Biotech

Viking Therapeutics, Inc. (NASDAQ: VKTX), a clinical-stage biopharmaceutical company, is gaining significant attention in the investor community due to its promising pipeline and remarkable upside potential...

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Unpacking a 36.64% Potential Upside in Rare Disease Biotech

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is gaining attention from investors with its significant potential upside of 36.64%, according to the latest analyst ratings. This Boston-based biotechnology..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Is a 15.86% Potential Upside Enough to Attract Investors?

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) has made a name for itself in the biotechnology sector, focusing on groundbreaking RNA-targeted therapeutics and gene therapies for rare diseases...

Krystal Biotech, Inc. (KRYS) Investor Outlook: A Promising Biotech with a 6% Upside Potential

Krystal Biotech, Inc. (NASDAQ: KRYS) is making waves in the biotechnology sector with its focus on developing genetic medicines for diseases with significant unmet medical needs...

Cytokinetics, Incorporated (CYTK) Stock Analysis: A Biotech Gem with a 44% Potential Upside

Cytokinetics, Incorporated (NASDAQ: CYTK), a pioneer in the biotechnology sector, is capturing investor attention with its impressive potential for growth. This late-stage biopharmaceutical company is focused..

Axsome Therapeutics (AXSM) Stock Analysis: A 63% Revenue Growth Fuels a Promising Biotech Play

For investors seeking dynamic opportunities in the biotechnology sector, Axsome Therapeutics, Inc. (NASDAQ: AXSM) presents an intriguing proposition. As a biopharmaceutical firm focused on central nervous..

Option Care Health, Inc. (OPCH) Stock Analysis: Riding a 17% Potential Upside Wave in the Healthcare Sector

Option Care Health, Inc. (NASDAQ: OPCH) is making waves in the healthcare sector, particularly within the medical care facilities industry, thanks to its innovative home and..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Strong Growth Potential Amidst Analyst Optimism

Inspire Medical Systems, Inc. (NASDAQ: INSP) stands as a compelling prospect in the healthcare sector, specifically within the burgeoning medical devices industry. Known for its innovative..

Prestige Consumer Healthcare (PBH) Stock Analysis: Is a 17.34% Potential Upside Worth the Investment?

Investors looking for opportunities in the healthcare sector might find Prestige Consumer Healthcare Inc. (NYSE: PBH) an intriguing prospect, especially given the company’s potential upside of..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Navigating its Growth Trajectory with 3.39% Potential Upside

Akero Therapeutics, Inc. (NASDAQ: AKRO), a burgeoning entity in the biotechnology sector, has caught the attention of investors with its focus on developing groundbreaking treatments for..

RadNet, Inc. (RDNT) Stock Analysis: Unpacking a 32% Upside Potential Amid Healthcare Expansion

RadNet, Inc. (NASDAQ: RDNT), a pivotal player in the Healthcare sector and specialized in the Diagnostics & Research industry, is capturing investor attention with its remarkable..

BrightSpring Health Services (BTSG) Rating Update: 16 Buy Ratings Signal Strong Growth Potential

BrightSpring Health Services, Inc. (BTSG) stands out in the healthcare sector, delivering robust growth and attracting significant investor interest. With a market capitalization of $7.16 billion,..

Genmab A/S (GMAB) Stock Analysis: Biotechnology Giant Poised for 22.75% Upside with Strong Buy Ratings

Investors eyeing the healthcare sector often turn their attention to Genmab A/S (NASDAQ: GMAB), a leading biotechnology company headquartered in Copenhagen, Denmark. With a robust market..

Revvity, Inc. (RVTY) Stock Analysis: A Potential 17.69% Upside in the Healthcare Diagnostics Sector

For investors with an interest in the healthcare sector, Revvity, Inc. (NYSE: RVTY) presents a compelling opportunity. With a market capitalization of $11.79 billion, this U.S.-based..

BioNTech SE (BNTX) Stock Analysis: A 31.79% Upside Potential Amidst Promising Clinical Trials

BioNTech SE (NASDAQ: BNTX), a leading player in the biotechnology sector, has been making waves in the healthcare industry with its cutting-edge immunotherapies targeting cancer and..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 53.95% Potential Upside

TG Therapeutics, Inc. (NASDAQ: TGTX) is making waves in the biotechnology sector with its innovative approach to treating B-cell mediated diseases. As a commercial-stage biopharmaceutical company,..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A 169.50% Potential Upside Amid Clinical Advancements

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is generating considerable buzz in the healthcare sector with its promising stock potential. As a clinical-stage biopharmaceutical company, Soleno is dedicated..

Avantor, Inc. (AVTR)

⚠️ No article content returned.

..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating the Healthcare Sector with a 28.90% Upside Potential

Oscar Health, Inc. (NYSE: OSCR) is carving out its niche in the competitive healthcare sector. As a technology-driven healthcare company, Oscar Health offers an array of..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating Growth with a 2.72% Upside Potential

Dr. Reddy’s Laboratories Ltd (NYSE: RDY) continues to be a significant player in the global healthcare sector, primarily within the drug manufacturing industry for specialty and..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds